Skip to main content

Illinois IGB

SimBioSys

SimBioSys Raises $15 Million in Series A funding

October 26, 2021

SimBioSys announced today it raised $15 million in Series A funding to accelerate the development and commercialization of its TumorScope software platform. The company’s novel, simulation-based, precision medicine platform enables individualized treatment planning for cancer patients.

This Series A was co-led by Genoa Ventures and Northpond Ventures, with participation from AV8 Ventures, Heritage Medical Group, and Mayo Clinic. Existing investors and founders also participated in this financing round, bringing the company’s total capital raised to $21 million.


October 26, 2021


Related Articles

Subscribe to SimBioSys